As life science companies have evolved to achieve greater scale and operational efficiency and cope with rapid changes in technology and regulatory requirements, they have also become increasingly complex, highly matrixed organizations with more specialized roles and processes. While these changes are necessary and beneficial in many respects, they can also have some adverse effects, such as greater fragmentation, functional silos, diffuse accountability, and goal misalignment.
A more integrated, end-to-end approach to clinical development has the capacity to positively impact quality, cycle time, and costs, building stronger organizations and talent. Specifically, this approach supports the greater alignment of goals and priorities, greater integration across different functions and parts of the process, reduction in ineffectual work, faster decision- making, and improved communication.
Download this white paper for practical strategies on fostering an end-to-end approach to clinical development, including:
- Organizational Design
- Team Structure
- Process Design
- Talent Development
- And more!